Inhibitory effect of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain) on ovalbumin antigenicity and antiovalbumin IgE antibody response in mice

Drugs under Experimental and Clinical Research

Volumn 22, Issue 3-5, 1996, Pages 195-200

  Wyczolkowska J ^a   Michon T ^a   Nowicky, J W ^b  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b Ukrainian Anti Cancer Institute   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ALKALOID DERIVATIVE; ALUMINUM POTASSIUM SULFATE; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; OVALBUMIN; PHOSPHOROTHIOIC ACID DERIVATIVE; UKRAIN;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGENICITY; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTAMINE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PERITONEUM MAST CELL; RAT; SENSITIZATION; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ALKALOIDS; ANAPHYLAXIS; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN E; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OVALBUMIN; PHENANTHRIDINES; RATS; RATS, WISTAR;

EID: 0029814619     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Nowicky J. W., Staniszewski A., Zbroja-Sontag W., Slesak B., Nowicky W., Hiesmyar W., Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium maius L. (Ukrain) as an immunostimulant in patients with various carcinomas. Drugs Exptl. Clin. Res., 17, 139, 1991.
2. Nowicky J.W. et al., Evaluation of clinical studies of Ukrain in cancer patients. J. Chemotherapy (Suppl.), 522, 1991.
3. Liepins A., Nowicky J.W., Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative Ukrain. Int. J. Immunopharmacol., 14, 1437, 1992.
4. Wyczółkowska J., Czuwaj M., Maśliński Cz., The immunomodulating preparation Ukrain does not induce anaphylactic sensitization in mice and guinea pigs Drugs Exptl. Clin. Res., XVIII (Suppl.), 35, 1992.
5. Mota I., Wong D., Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sci., 8, 813, 1969.
6. Katayama S., Shionoya H., Ohtake S., A new method for extraction of extravasated dye in the skin and the influence of fasting stress on passive cutaneous anaphylaxis in guinea pigs and rats. Microbiol. Immunol., 22, 89-101, 1978.
7. Wyczółkowska J., Brzezińska-Błaszczyk, Maśliński C., Kinetics of specific IgE antibody and total IgE responses in mice: the effect of immunosuppressive treatment. Int. Arch Allergy Appl. Immunol., 72, 16-21, 1983.
8. May Ch.D., Lyman M., Alberto R., Cheng J., Procedures for immunochemical study of histamine release from leukocytes with small volume of blood. J. Allergy, 46, 12-20, 1970.
9. Takatsu K., Ishizaka K., Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody response to ovalbumin following the administration of high dose ureadenaturated antigen. Cell. Immunol., 20, 276, 1975.
10. HayGlass K.T., Strejan G.H., Suppression of the IgE antibody response by glutaraldehyde-modified ovalbumin: dissociation between loss of antigenic reactivity and ability to induce suppression. Int. Arch. Allergy Appl. Immunol., 74, 332-340, 1984.
11. Lee W.Y., Sehon A.M., Suppression of reaginic antibodies with modified allergens. I. Reduction of allergenicity of protein allergens by conjugation of polyethylene glycol. Int. Arch, Allergy Appl. Immunol., 56, 159-170, 1978.
12. Liu F.T., Katz D.H., Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production. Proc. Natl. Acad. Sci. (USA), 76, 1430-1434, 1979.
13. Ishizaka K., Regulation of immunoglobulin E biosynthesis. Adv. Immunol., 47, 1-44, 1989.
14. Marsh D.G., Norman P.S., Roebber M., Lichtenstein C.M., Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification of two steps. J. Allergy Clin. Immunol., 68, 449-459, 1981.
15. Puttonen E., Maasch H.J., Pilstrom L., Studies on allergen and allergoid preparations from purified timothy pollen extracts. I . Physicochemical characteristics and binding to allergen-specific human IgE. Int. Arch, Allergy Appl. Immun., 68, 1-6, 1982.